Moderator: Mike Rice, MS, MBA, Senior Consultant, Defined Health Panelists: Estuardo Aguilar-Cordova, PhD, Chief Executive Officer Advantagene, Inc. Harry Gruber, MD, Chairman, Tocagen, Inc. Angela Shen, MD, MBA, Global Clinical Program Head, CTL019, Oncology Clinical Development, Novartis Pharmaceuticals Corp
Category: News
Antibody-Drug Conjugates: Supercharging the Blockbuster Antibody Class
Moderator: Jeff Bockman, PhD, VP, Defined Health Panelists: Robert Cohen, MD, Calico Life Sciences Jonathan Drachman, MD, SVP, Research and Translational Medicine, Seattle Genetics Hans-Peter Gerber, PhD, VP, BioConjugate Discovery & Development, Oncology Research, Pfizer John Lambert, PhD, EVP, Research & Development & Chief Scientific Officer, ImmunoGen, Inc. Peter Kiener, Ph D, Chief Scientific Officer, […]
Big Data and Cancer: Transforming Patient Care by Turning Data into Decisions
Moderator: Colin Hill, Chief Executive Officer, President & Chairman, GNS Healthcare Panelists: Alexis Borisy, Entrepreneur in Residence, Third Rock Ventures Joel Dudley, PhD, Director of Biomedical Informatics and Assistant Professor of Genetics and Genomics Sciences, Icahn School of Medicine at Mount Sinai Brian Leyland-Jones, MD, VP, Molecular and Experimental Medicine, Avera Health Michael Kolodziej, MD, […]